CN101519428B - 一种l-丙氨酰-l-谷氨酰胺化合物及其合成方法 - Google Patents
一种l-丙氨酰-l-谷氨酰胺化合物及其合成方法 Download PDFInfo
- Publication number
- CN101519428B CN101519428B CN2009100142548A CN200910014254A CN101519428B CN 101519428 B CN101519428 B CN 101519428B CN 2009100142548 A CN2009100142548 A CN 2009100142548A CN 200910014254 A CN200910014254 A CN 200910014254A CN 101519428 B CN101519428 B CN 101519428B
- Authority
- CN
- China
- Prior art keywords
- alanyl
- glutamine
- compound
- solution
- temperature
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960002648 alanylglutamine Drugs 0.000 title claims abstract description 53
- -1 L-alanyl-L-glutamine compound Chemical class 0.000 title claims abstract description 21
- 238000010189 synthetic method Methods 0.000 title claims abstract description 11
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 48
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 27
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 8
- 239000000243 solution Substances 0.000 claims description 30
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 claims description 20
- GJRQTCIYDGXPES-UHFFFAOYSA-N iso-butyl acetate Natural products CC(C)COC(C)=O GJRQTCIYDGXPES-UHFFFAOYSA-N 0.000 claims description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 18
- FGKJLKRYENPLQH-UHFFFAOYSA-M isocaproate Chemical compound CC(C)CCC([O-])=O FGKJLKRYENPLQH-UHFFFAOYSA-M 0.000 claims description 17
- OQAGVSWESNCJJT-UHFFFAOYSA-N isovaleric acid methyl ester Natural products COC(=O)CC(C)C OQAGVSWESNCJJT-UHFFFAOYSA-N 0.000 claims description 17
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- 239000011541 reaction mixture Substances 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 239000012074 organic phase Substances 0.000 claims description 10
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 claims description 9
- 230000004224 protection Effects 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 7
- 239000007864 aqueous solution Substances 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 5
- 238000002425 crystallisation Methods 0.000 claims description 5
- 230000008025 crystallization Effects 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 238000001953 recrystallisation Methods 0.000 claims description 5
- 230000001143 conditioned effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000746 purification Methods 0.000 claims description 2
- 230000006378 damage Effects 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- 229960003767 alanine Drugs 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 239000003960 organic solvent Substances 0.000 description 9
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- 230000003287 optical effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- 230000009102 absorption Effects 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000000903 blocking effect Effects 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 238000005261 decarburization Methods 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 238000004611 spectroscopical analysis Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- 239000003643 water by type Substances 0.000 description 3
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 2
- 108010016626 Dipeptides Proteins 0.000 description 2
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- HOGDNTQCSIKEEV-UHFFFAOYSA-N n'-hydroxybutanediamide Chemical compound NC(=O)CCC(=O)NO HOGDNTQCSIKEEV-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- VHHHONWQHHHLTI-UHFFFAOYSA-N hexachloroethane Chemical compound ClC(Cl)(Cl)C(Cl)(Cl)Cl VHHHONWQHHHLTI-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- TYRGLVWXHJRKMT-QMMMGPOBSA-N n-benzyloxycarbonyl-l-serine-betalactone Chemical compound OC(=O)[C@H](C)NC(=O)OCC1=CC=CC=C1 TYRGLVWXHJRKMT-QMMMGPOBSA-N 0.000 description 1
- CFHIDWOYWUOIHU-UHFFFAOYSA-N oxomethyl Chemical compound O=[CH] CFHIDWOYWUOIHU-UHFFFAOYSA-N 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100142548A CN101519428B (zh) | 2009-02-19 | 2009-02-19 | 一种l-丙氨酰-l-谷氨酰胺化合物及其合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100142548A CN101519428B (zh) | 2009-02-19 | 2009-02-19 | 一种l-丙氨酰-l-谷氨酰胺化合物及其合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101519428A CN101519428A (zh) | 2009-09-02 |
CN101519428B true CN101519428B (zh) | 2011-09-14 |
Family
ID=41080250
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100142548A Expired - Fee Related CN101519428B (zh) | 2009-02-19 | 2009-02-19 | 一种l-丙氨酰-l-谷氨酰胺化合物及其合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101519428B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102093250B (zh) * | 2010-12-02 | 2013-03-20 | 海南本创医药科技有限公司 | 一种丙氨酰谷氨酰胺化合物的精制方法 |
CN103012191B (zh) * | 2011-09-26 | 2015-04-22 | 重庆莱美药业股份有限公司 | 一种制备d-2-取代丙酰-l-谷氨酰胺的方法 |
CN103012550B (zh) * | 2011-09-26 | 2014-12-10 | 重庆莱美药业股份有限公司 | 一种制备n(2)-l-丙氨酰-l-谷氨酰胺的方法 |
CN102731613B (zh) * | 2012-07-18 | 2013-12-11 | 济南诚汇双达化工有限公司 | 一种l-丙氨酰-l-谷氨酰胺的制备方法 |
CN103073617B (zh) * | 2012-12-27 | 2014-03-05 | 西安万隆制药股份有限公司 | N(2)-l-丙氨酰-l-谷氨酰胺的化合物 |
CN103265616B (zh) * | 2013-04-24 | 2015-07-01 | 保定市龙瑞药物技术有限责任公司 | 一种n(2)-l-丙氨酰-l-谷氨酰胺的合成方法 |
CN107805275B (zh) * | 2016-09-08 | 2023-07-21 | 重庆莱美隆宇药业有限公司 | 一种新的n(2)-l-丙氨酰-l-谷氨酰胺晶型及其制备方法 |
CN110099919B (zh) * | 2016-12-20 | 2023-11-28 | 协和发酵生化株式会社 | L-丙氨酰-l-谷氨酰胺的晶体及其制造方法 |
-
2009
- 2009-02-19 CN CN2009100142548A patent/CN101519428B/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN101519428A (zh) | 2009-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101519428B (zh) | 一种l-丙氨酰-l-谷氨酰胺化合物及其合成方法 | |
CN110642897B (zh) | 一种β-烟酰胺核糖氯化物的制备方法 | |
CN112898220B (zh) | 一种n-(8-[2-羟基苯甲酰基]-氨基)辛酸钠及其中间体的制备方法 | |
CN106459150A (zh) | 合成五肽的制造方法 | |
CN108003105B (zh) | 一种合成小分子氨基酸衍生物依克多因的方法 | |
CN102093444A (zh) | 一种制备异帕米星及其盐的方法 | |
CN101781264B (zh) | 1-甲基-5-巯基-1,2,3,4-四氮唑的生产方法 | |
CN102070635B (zh) | 一种更昔洛韦缬氨酸酯衍生物的制备方法 | |
WO2014097306A1 (en) | Stable and pure polymorphic form of bortezomib | |
CN113735716B (zh) | 一种亚精胺的制备方法 | |
CN110872251A (zh) | N-乙基吡啶甲胺三氟乙酸盐及其晶体、制备工艺和应用 | |
CN106854179B (zh) | 地喹氯铵及其类似物的制备方法 | |
CN111051289A (zh) | 被保护的l-肌肽衍生物、l-肌肽以及结晶性l-肌肽锌络合物的制造方法 | |
CN115340481A (zh) | 一种采用固载镍催化工业化生产氘代医药中间体的方法 | |
IE50856B1 (en) | Method of producing n-benzyloxycarbonyl-l-aspartic acid | |
CN108147988B (zh) | 一种高手性纯度内酰胺化合物的制备方法 | |
JP4564375B2 (ja) | テアニンの製造方法 | |
CN109265385B (zh) | 一种手性催化剂的合成工艺 | |
JP2012020970A (ja) | {2−アミノ−1,4−ジヒドロ−6−メチル−4−(3−ニトロフェニル)−3,5−ピリジンジカルボン酸3−(1−ジフェニルメチルアゼチジン−3−イル)エステル5−イソプロピルエステル}の製造方法 | |
CN108203396B (zh) | 一种脑啡肽酶抑制剂的合成 | |
CN101381341A (zh) | 3-羟基-6-羟甲基吡啶的制备方法 | |
WO2013159283A1 (zh) | 一种制备(s)−奥拉西坦的方法 | |
CN108623598A (zh) | 一种亚胺培南中间体及亚胺培南的制备方法 | |
CN109970620A (zh) | 一种制备沙格列汀中间体的方法 | |
CN113754630B (zh) | 一种α-硫辛酸的合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Hainan Lingkang Pharmaceutical Co., Ltd. Assignor: Zhang Xifen Contract record no.: 2011990001061 Denomination of invention: L-alanyl-L-glutamine compound and synthetic method thereof Granted publication date: 20110914 License type: Exclusive License Open date: 20090902 Record date: 20111128 |
|
ASS | Succession or assignment of patent right |
Owner name: HAINAN LINGKANG PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: ZHANG XIFEN Effective date: 20120604 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 310052 HANGZHOU, ZHEJIANG PROVINCE TO: 570216 HAIKOU, HAINAN PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20120604 Address after: 570216 No. 8 workshop, Haikou Free Trade Zone, Hainan Patentee after: Hainan Lingkang Pharmaceutical Co., Ltd. Address before: 310052, Zhejiang, Hangzhou province Binjiang District foreshore road watermark city 3, room 1602 Patentee before: Zhang Xifen |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20130726 Address after: 570216 Hainan Province, Haikou city Jinpan Industrial Development Zone Industrial Village No. 3-6 building Patentee after: Hainan Lingkang Pharmaceutical Co., Ltd. Address before: 570216 No. 8 workshop, Haikou Free Trade Zone, Hainan Patentee before: Hainan Lingkang Pharmaceutical Co., Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Hainan Lingkang Pharmaceutical Co., Ltd. Document name: Notification to Pay the Fees |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110914 Termination date: 20160219 |
|
CF01 | Termination of patent right due to non-payment of annual fee |